Please Wait.....
Report
North America Endoscopic Hemostasis Market
Market Report I 2026-01-01 I 350 Pages I Data Bridge Market Research
The North America Endoscopic Hemostasis Market is expected to reach USD 1,563.38 Million by 2033 from USD 880.69 Million in 2025, growing with a substantial CAGR of 7.9% in the forecast period of 2026 to 2033.
Market Segmentation:
North America Endoscopic Hemostasis Market, By Product Type (Mechanical Hemostasis Devices, Thermal Devices, Topical Agents And Injectables, and Others), Procedure (Upper Gastrointestinal Endoscopy, Lower Gastrointestinal Endoscopy, Bronchoscopic Hemostasis, and Others), By Application (Gastrointestinal Bleeding, Non-Gastrointestinal Bleeding, Trauma Management, and Others), By End User (Hospitals (Public and Private), Ambulatory Surgery Centers, Specialty Clinics, and Others), By Distribution Channel (Direct Sales and Indirect Sales), By Countries (U.S., Canada, and Mexico)- Industry Trends and Forecast to 2033
Overview of North America Endoscopic Hemostasis Market Dynamics:
Drivers
- Rise in gastrointestinal bleeding cases
- Aging population driving increased demand for GI disorders
- Adoption of minimally invasive endoscopic procedures
- Rising awareness and expanded screening programs for gastrointestinal endoscopy
Restraints
- High cost and technical complexity of endoscopic hemostasis devices
- Limited awareness in low-income countries
Opportunities
- Technological advancements in hemostasis devices
- Expansion in emerging markets (Asia-Pacific, Latin America)
- Growing adoption of home-based and capsule endoscopy solutions
Market Players:
The key market players operating in the North America Endoscopic Hemostasis Market are listed below:
- Micro-Tech Endoscopy (China)
- Taewoong Medical Co., Ltd. (South Korea)
- Ovesco Endoscopy AG (China)
- Apollo Endosurgery, Inc. (U.S.)
- Argon Medical Devices, Inc. (U.S.)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (U.S.)
- CONMED Corporation (U.S.)
- Medtronic (Ireland)
- Cook (U.S.)
- ERBE Elektromedizin GmbH (China)
- Karl Storz SE & Co. KG (China)
- Pentax Medical (Japan)
- Endoskopie Technik Gerhard (China)
- Merit Medical Systems, Inc. (U.S.)
- Diversatek, Inc. (U.S.)
- STERIS plc (Japan)
- B. Braun SE (China)
- Duomed Group (Belgium)
TABLE OF CONTENTS
1 INTRODUCTION 82
1.1 OBJECTIVES OF THE STUDY 82
1.2 MARKET DEFINITION 82
1.3 OVERVIEW OF NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET 82
1.4 LIMITATIONS 84
1.5 MARKETS COVERED 85
2 MARKET SEGMENTATION 87
2.1 MARKETS COVERED 87
2.2 GEOGRAPHICAL SCOPE 88
2.3 YEARS CONSIDERED FOR THE STUDY 89
2.4 CURRENCY AND PRICING 89
2.5 DBMR TRIPOD DATA VALIDATION MODEL 90
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 93
2.7 MULTIVARIATE MODELLING 94
2.8 DBMR MARKET POSITION GRID 95
2.9 VENDOR SHARE ANALYSIS 96
2.10 MARKET END-USER COVERAGE GRID 97
2.11 SECONDARY SOURCES 98
2.12 ASSUMPTIONS 98
3 EXECUTIVE SUMMARY 99
4 PREMIUM INSIGHTS 105
4.1 PORTERS FIVE FORCES ANALYSIS 106
4.2 BRAND OUTLOOK 107
4.2.1 BRAND COMPARATIVE ANALYSIS OF KEY NORTH AMERICA PLAYERS 107
4.2.1.1 BRAND COMPARATIVE NARRATIVE (ANALYTICAL OVERVIEW) 108
4.2.2 PRODUCT VS BRAND OVERVIEW - NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET 109
4.2.2.1 PRODUCT OVERVIEW - ENDOSCOPIC HEMOSTASIS DEVICES 109
4.2.2.2 BRAND OVERVIEW - INFLUENCE ON NORTH AMERICA CLINICAL ADOPTION 109
4.3 CONSUMER BUYING BEHAVIOUR 110
4.3.1 CLINICAL EFFECTIVENESS AND PATIENT OUTCOMES 110
4.3.2 COST AND VALUE CONSIDERATIONS 110
4.3.3 COMPATIBILITY AND INTEGRATION 110
4.3.4 TRAINING REQUIREMENTS AND EASE OF USE 110
4.3.5 REIMBURSEMENT AND HEALTHCARE POLICY ALIGNMENT 110
4.3.6 PROCUREMENT PROCESSES AND BULK AGREEMENTS 111
4.3.7 INFLUENCE OF CLINICAL STAKEHOLDERS 111
4.3.8 TRENDS IN BUYER BEHAVIOUR 111
4.3.9 CONCLUSION 111
4.4 PATENT ANALYSIS 112
4.4.1 PATENT QUALITY AND STRENGTH - NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET 112
4.4.2 COUNTRY PATENT LANDSCAPE 112
4.4.3 IP STRATEGY AND MANAGEMENT 114
4.4.4 LICENSING AND COLLABORATION 114
4.5 RAW MATERIAL COVERAGE 116
4.5.1 METALLIC COMPONENTS AND ALLOY SYSTEMS 116
4.5.2 POLYMERIC AND SYNTHETIC MATERIALS 116
4.5.3 NATURAL AND BIOCOMPATIBLE MATERIALS 116
4.5.4 ELECTRICAL AND THERMAL MATERIAL SYSTEMS 117
4.5.5 EXPENDABLE ACCESSORIES AND SINGLE-USE MATERIALS 117
4.6 TECHNOLOGICAL ADVANCEMENTS IN NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET 118
4.6.1 ENHANCED MECHANICAL HEMOSTASIS TOOLS 118
4.6.2 ADVANCED THERMAL COAGULATION AND ENERGY-BASED SYSTEMS 118
4.6.3 NOVEL TOPICAL HEMOSTATIC AGENTS 118
4.6.4 INTEGRATION WITH ADJUNCTIVE DIAGNOSTIC TECHNOLOGIES 118
4.6.5 DEVELOPMENT OF MULTIFUNCTIONAL AND COMBINATION DEVICES 118
4.6.6 IMPROVED USER ERGONOMICS AND DEVICE DEPLOYMENT SYSTEMS 119
4.6.7 CONCLUSION 119
4.7 VALUE CHAIN ANALYSIS 120
4.7.1 OVERVIEW 120
4.7.2 RAW MATERIALS & COMPONENTS 120
4.7.3 DEVICE DESIGN, R&D & MANUFACTURING 121
4.7.4 PROCESSING, FINISHING & STERILIZATION 121
4.7.5 PACKAGING & LABELING 121
4.7.6 LOGISTICS, DISTRIBUTION & COMMERCIALIZATION 121
4.7.7 CONCLUSION 121
4.8 VENDOR SELECTION CRITERIA 122
4.8.1 CLINICAL PERFORMANCE 122
4.8.2 REGULATORY COMPLIANCE AND APPROVALS 122
4.8.3 COST AND TOTAL VALUE PROPOSITION 122
4.8.4 SUPPLY CHAIN ROBUSTNESS AND LOGISTICS 122
4.8.5 SUPPORT, TRAINING AND CLINICAL EDUCATION 122
4.8.6 QUALITY SYSTEMS AND REPROCESSING GUIDANCE 122
4.8.7 REPUTATION, PEER ACCEPTANCE AND POST-MARKET PERFORMANCE 122
4.8.8 INNOVATION AND FUTURE-READINESS 123
4.9 COMPANY EVALUATION QUADRANT 124
4.10 PROFIT MARGIN SCENARIO 126
4.10.1 MARGIN IMPROVEMENT DRIVERS 126
4.10.2 COST PRESSURE 126
4.10.3 REGIONAL VARIATIONS 126
4.10.4 FUTURE SCENARIOS 127
4.11 CLIMATE CHANGE SCENARIO 128
4.11.1 ENVIRONMENTAL CONCERNS 128
4.11.2 INDUSTRY RESPONSE 128
4.11.3 GOVERNMENT'S ROLE 128
4.11.4 ANALYST RECOMMENDATIONS 129
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS 130
4.12.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 130
4.12.1.1 JOINT VENTURES 130
4.12.1.2 MERGERS AND ACQUISITIONS 130
4.12.1.3 LICENSING AND PARTNERSHIP 130
4.12.1.4 TECHNOLOGY COLLABORATIONS 130
4.12.2 STRATEGIC DIVESTMENTS 131
4.12.3 STAGE OF DEVELOPMENT 131
4.12.4 TIMELINES AND MILESTONES 131
4.12.5 INNOVATION STRATEGIES AND METHODOLOGIES 131
4.12.6 RISK ASSESSMENT AND MITIGATION 131
4.12.7 FUTURE OUTLOOK 132
4.13 PRICING ANALYSIS 133
4.13.1 HEMOSTATIC CLIPS AND FORCEPS PRICING 133
4.13.2 BANDING AND COAGULATION DEVICES 134
4.13.3 REGULATORY AND REIMBURSEMENT IMPACT 134
4.14 SUPPLY CHAIN ANALYSIS 135
4.14.1 OVERVIEW 135
4.14.2 LOGISTIC COST SCENARIO 135
4.14.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 135
4.14.4 CONCLUSION 136
5 TARIFFS & IMPACT ON THE MARKET 137
5.1 OVERVIEW 137
5.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 137
5.3 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 137
5.4 VENDOR SELECTION CRITERIA 138
5.5 IMPACT ON SUPPLY CHAIN 138
5.5.1 RAW MATERIAL PROCUREMENT 138
5.5.2 MANUFACTURING AND PRODUCTION 138
5.5.3 LOGISTICS AND DISTRIBUTION 138
5.5.4 PRICE PITCHING AND POSITION OF MARKET 138
5.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 138
5.6.1 SUPPLY CHAIN OPTIMIZATION 138
5.6.2 JOINT VENTURE ESTABLISHMENTS 138
5.7 IMPACT ON PRICES 139
5.8 REGULATORY INCLINATION 139
5.8.1 GEOPOLITICAL SITUATION 139
5.8.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 139
5.8.2.1 FREE TRADE AGREEMENTS 139
5.8.2.2 ALLIANCES ESTABLISHMENTS 139
5.8.3 STATUS ACCREDITATION (INCLUDING MFTN) 139
5.8.4 DOMESTIC COURSE OF CORRECTION 139
5.8.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 139
5.8.4.2 ESTABLISHMENT OF SEZS/INDUSTRIAL PARKS 139
6 REGULATION COVERAGE 140
6.1 PRODUCT CODES 140
6.2 CERTIFIED STANDARDS 140
6.3 SAFETY STANDARDS 141
6.3.1 MATERIAL HANDLING & STORAGE 141
6.3.2 TRANSPORT & PRECAUTIONS 141
6.3.3 HAZARD IDENTIFICATION 141
7 MARKET OVERVIEW 142
7.1 DRIVERS 144
7.1.1 RISE IN GASTROINTESTINAL BLEEDING CASES 144
7.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI DISORDERS 145
7.1.3 ADOPTION OF MINIMALLY INVASIVE ENDOSCOPIC PROCEDURES 146
7.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 147
7.2 RESTRAINTS 148
7.2.1 HIGH COST AND TECHNICAL COMPLEXITY OF ENDOSCOPIC HEMOSTASIS DEVICES 148
7.2.2 LIMITED AWARENESS IN LOW-INCOME COUNTRIES 149
7.3 OPPORTUNITIES 150
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEMOSTASIS DEVICES 150
7.3.2 EXPANSION IN EMERGING MARKETS (ASIA-PACIFIC, LATIN AMERICA) 151
7.3.3 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 152
7.4 CHALLENGES 153
7.4.1 REIMBURSEMENT ISSUES FOR ENDOSCOPIC PROCEDURES 153
7.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 154
8 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 155
8.1 OVERVIEW 156
8.2 MECHANICAL HEMOSTASIS DEVICES 159
8.2.1 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 159
8.2.1.1 HEMOSTATIC CLIPS 160
8.2.1.1.1 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 160
8.2.1.1.1.1 THROUGH-THE-SCOPE (TTS) CLIPS 160
8.2.1.1.1.2 OVER-THE-SCOPE (OTS) CLIPS 160
8.2.1.1.2 HEMOSTATIC CLIPS IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY MATERIAL 161
8.2.1.1.2.1 STAINLESS STEEL 161
8.2.1.1.2.2 TITANIUM 161
8.2.1.2 BANDING DEVICES 162
8.2.1.2.1 BANDING DEVICES IN MECHANICAL HEMOSTASIS DEVICES MARKET, BY TYPE 162
8.2.1.2.1.1 VARICEAL BANDING KITS 162
8.2.1.2.1.2 OESOPHAGEAL BANDING DEVICES 162
8.2.1.3 HEMOSTATIC FORCEPS 162
8.2.1.4 OTHERS 162
8.2.2 MECHANICAL HEMOSTASIS DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 163
8.2.2.1 NORTH AMERICA 163
8.2.2.2 EUROPE 163
8.2.2.3 ASIA-PACIFIC 163
8.2.2.4 SOUTH AMERICA 163
8.2.2.5 MIDDLE EAST & AFRICA 163
8.3 THERMAL DEVICES 164
8.3.1 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 164
8.3.1.1 ARGON PLASMA COAGULATORS 164
8.3.1.2 HEATER PROBES 164
8.3.1.3 BIPOLAR COAGULATION DEVICES 164
8.3.1.3.1 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY ENERGY TYPE 165
8.3.1.3.1.1 MONOPOLAR 165
8.3.1.3.1.2 BIPOLAR 165
8.3.1.3.2 BIPOLAR COAGULATION IN THERMAL DEVICES MARKET, BY APPLICATION 166
8.3.1.3.2.1 UPPER GI BLEEDING 166
8.3.1.3.2.2 LOWER GI BLEEDING 166
8.3.1.4 OTHERS 166
8.3.2 THERMAL DEVICES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 167
8.3.2.1 NORTH AMERICA 167
8.3.2.2 EUROPE 167
8.3.2.3 ASIA-PACIFIC 167
8.3.2.4 SOUTH AMERICA 167
8.3.2.5 MIDDLE EAST & AFRICA 167
8.4 TOPICAL AGENTS AND INJECTABLES 168
8.4.1 TOPICAL AGENTS & INJECTIBLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 168
8.4.1.1 EPINEPHRINE INJECTION 168
8.4.1.2 HEMOSTATIC SPRAY (POWDER) 168
8.4.1.3 HEMOSTATIC GELS 168
8.4.1.4 FIBRIN SEALANTS 169
8.4.1.5 SCLEROSING AGENTS 169
8.4.2 TOPICAL AGENTS AND INJECTABLES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 169
8.4.2.1 NORTH AMERICA 169
8.4.2.2 EUROPE 169
8.4.2.3 ASIA-PACIFIC 169
8.4.2.4 SOUTH AMERICA 170
8.4.2.5 MIDDLE EAST & AFRICA 170
8.5 OTHERS 170
8.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 170
8.5.1.1 NORTH AMERICA 170
8.5.1.2 EUROPE 170
8.5.1.3 ASIA-PACIFIC 171
8.5.1.4 SOUTH AMERICA 171
8.5.1.5 MIDDLE EAST & AFRICA 171
9 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY PROCEDURE TYPE 172
9.1 OVERVIEW 173
9.2 UPPER GASTROINTESTINAL ENDOSCOPY 175
9.2.1 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 175
9.2.1.1 BLEEDING ULCER MANAGEMENT 176
9.2.1.2 VARICEAL BLEEDING 176
9.2.1.3 DIEULAFOY LESION 176
9.2.2 UPPER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 176
9.2.2.1 NORTH AMERICA 176
9.2.2.2 EUROPE 176
9.2.2.3 ASIA-PACIFIC 177
9.2.2.4 SOUTH AMERICA 177
9.2.2.5 MIDDLE EAST & AFRICA 177
9.3 LOWER GASTROINTESTINAL ENDOSCOPY 177
9.3.1 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 177
9.3.1.1 COLONIC BLEEDING 177
9.3.1.2 DIVERTICULAR BLEEDING 178
9.3.2 LOWER GASTROINTESTINAL ENDOSCOPY IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 178
9.3.2.1 NORTH AMERICA 178
9.3.2.2 EUROPE 178
9.3.2.3 ASIA-PACIFIC 178
9.3.2.4 SOUTH AMERICA 178
9.3.2.5 MIDDLE EAST & AFRICA 179
9.4 BRONCHOSCOPIC HEMOSTASIS 179
9.4.1 BRONCHOSCOPIC HEMOSTASIS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 179
9.4.1.1 NORTH AMERICA 179
9.4.1.2 EUROPE 179
9.4.1.3 ASIA-PACIFIC 179
9.4.1.4 SOUTH AMERICA 180
9.4.1.5 MIDDLE EAST & AFRICA 180
9.5 OTHERS 180
9.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 180
9.5.1.1 NORTH AMERICA 180
9.5.1.2 EUROPE 180
9.5.1.3 ASIA-PACIFIC 181
9.5.1.4 SOUTH AMERICA 181
9.5.1.5 MIDDLE EAST & AFRICA 181
10 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY APPLICATION 182
10.1 OVERVIEW 183
10.2 GASTROINTESTINAL BLEEDING 186
10.2.1 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 186
10.2.1.1 PEPTIC ULCER BLEEDING 187
10.2.1.2 ESOPHAGEAL VARICES 187
10.2.1.3 COLORECTAL CANCERS 187
10.2.2 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 187
10.2.2.1 MECHANICAL HEMOSTASIS DEVICES 187
10.2.2.2 THERMAL DEVICES 188
10.2.2.3 TOPICAL AGENTS AND INJECTABLES 188
10.2.2.4 OTHERS 188
10.2.3 GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 188
10.2.3.1 NORTH AMERICA 188
10.2.3.2 EUROPE 188
10.2.3.3 ASIA-PACIFIC 189
10.2.3.4 SOUTH AMERICA 189
10.2.3.5 MIDDLE EAST & AFRICA 189
10.3 NON-GASTROINTESTINAL BLEEDING 189
10.3.1 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 189
10.3.1.1 NASAL BLEEDING (EPISTAXIS) 189
10.3.1.2 POST-SURGICAL BLEEDING 190
10.3.2 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 190
10.3.2.1 MECHANICAL HEMOSTASIS DEVICES 190
10.3.2.2 THERMAL DEVICES 190
10.3.2.3 TOPICAL AGENTS & INJECTABLES 190
10.3.2.4 OTHERS 191
10.3.3 NON-GASTROINTESTINAL BLEEDING IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION, 2018-2033, (USD THOUSAND) 191
10.3.3.1 NORTH AMERICA 191
10.3.3.2 EUROPE 191
10.3.3.3 ASIA-PACIFIC 191
10.3.3.4 SOUTH AMERICA 191
10.3.3.5 MIDDLE EAST & AFRICA 192
10.4 TRAUMA MANAGEMENT 192
10.4.1 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE 192
10.4.1.1 MECHANICAL HEMOSTASIS DEVICES 192
10.4.1.2 THERMAL DEVICES 192
10.4.1.3 TOPICAL AGENTS & INJECTABLES 193
10.4.1.4 OTHERS 193
10.4.2 TRAUMA MANAGEMENT IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 193
10.4.2.1 NORTH AMERICA 193
10.4.2.2 EUROPE 193
10.4.2.3 ASIA-PACIFIC 193
10.4.2.4 SOUTH AMERICA 194
10.4.2.5 MIDDLE EAST & AFRICA 194
10.5 OTHERS 194
10.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 194
10.5.1.1 NORTH AMERICA 194
10.5.1.2 EUROPE 194
10.5.1.3 ASIA-PACIFIC 195
10.5.1.4 SOUTH AMERICA 195
10.5.1.5 MIDDLE EAST & AFRICA 195
11 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY END USER 196
11.1 OVERVIEW 197
11.2 HOSPITALS 200
11.2.1 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY TYPE 200
11.2.1.1 PUBLIC 200
11.2.1.2 PRIVATE 200
11.2.2 HOSPITALS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 201
11.2.2.1 NORTH AMERICA 201
11.2.2.2 EUROPE 201
11.2.2.3 ASIA-PACIFIC 201
11.2.2.4 SOUTH AMERICA 201
11.2.2.5 MIDDLE EAST & AFRICA 201
11.3 AMBULATORY SURGERY CENTERS 202
11.3.1 AMBULATORY SURGERY CENTERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 202
11.3.1.1 NORTH AMERICA 202
11.3.1.2 EUROPE 202
11.3.1.3 ASIA-PACIFIC 202
11.3.1.4 SOUTH AMERICA 202
11.3.1.5 MIDDLE EAST & AFRICA 203
11.4 SPECIALTY CLINICS 203
11.4.1 SPECIALTY CLINICS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 203
11.4.1.1 NORTH AMERICA 203
11.4.1.2 EUROPE 203
11.4.1.3 ASIA-PACIFIC 203
11.4.1.4 SOUTH AMERICA 204
11.4.1.5 MIDDLE EAST & AFRICA 204
11.5 OTHERS 204
11.5.1 OTHERS IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 204
11.5.1.1 NORTH AMERICA 204
11.5.1.2 EUROPE 204
11.5.1.3 ASIA-PACIFIC 205
11.5.1.4 SOUTH AMERICA 205
11.5.1.5 MIDDLE EAST & AFRICA 205
12 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY DISTRIBUTION CHANNEL 206
12.1 OVERVIEW 207
12.2 INDIRECT SALES 210
12.2.1 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS, BY TYPE 210
12.2.1.1 OFFLINE 210
12.2.1.2 ONLINE 210
12.2.2 INDIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 211
12.2.2.1 NORTH AMERICA 211
12.2.2.2 EUROPE 211
12.2.2.3 ASIA-PACIFIC 211
12.2.2.4 SOUTH AMERICA 211
12.2.2.5 MIDDLE EAST & AFRICA 211
12.3 DIRECT SALES 212
12.3.1 DIRECT SALES IN ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 212
12.3.1.1 NORTH AMERICA 212
12.3.1.2 EUROPE 212
12.3.1.3 ASIA-PACIFIC 212
12.3.1.4 SOUTH AMERICA 212
12.3.1.5 MIDDLE EAST & AFRICA 213
13 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET, BY REGION 214
13.1 NORTH AMERICA 216
13.1.1 U.S. 226
13.1.2 CANADA 236
13.1.3 MEXICO 246
14 NORTH AMERICA ENDOSCOPIC HEMOSTASIS MARKET: COMPANY LANDSCAPE 256
14.1 COMPANY SHARE ANALYSIS: GLOBAL 256
15 SWOT ANALYSIS 257
16 COMPANY PROFILES MANUFACTURERS 258
16.1 OLYMPUS CORPORATION 258
16.1.1 COMPANY SNAPSHOT 258
16.1.2 REVENUE ANALYSIS 258
16.1.3 COMPANY SHARE ANALYSIS 259
16.1.4 PRODUCT PORTFOLIO 259
16.1.5 RECENT DEVELOPMENT 260
16.2 BOSTON SCIENTIFIC CORPORATION 261
16.2.1 COMPANY SNAPSHOT 261
16.2.2 REVENUE ANALYSIS 261
16.2.3 COMPANY SHARE ANALYSIS 262
16.2.4 PRODUCT PORTFOLIO 262
16.2.5 RECENT DEVELOPMENT 263
16.3 CONMED CORPORATION 264
16.3.1 COMPANY SNAPSHOT 264
16.3.2 REVENUE ANALYSIS 264
16.3.3 COMPANY SHARE ANALYSIS 265
16.3.4 PRODUCT PORTFOLIO 265
16.3.5 RECENT DEVELOPMENT 266
16.4 MEDTRONIC 267
16.4.1 COMPANY SNAPSHOT 267
16.4.2 REVENUE ANALYSIS 267
16.4.3 COMPANY SHARE ANALYSIS 268
16.4.4 PRODUCT PORTFOLIO 268
16.4.5 RECENT DEVELOPMENT 269
16.5 COOK 270
16.5.1 COMPANY SNAPSHOT 270
16.5.2 COMPANY SHARE ANALYSIS 270
16.5.3 PRODUCT PORTFOLIO 271
16.5.4 RECENT DEVELOPMENT 272
16.6 ANKAFERD 273
16.6.1 COMPANY SNAPSHOT 273
16.6.2 PRODUCT PORTFOLIO 273
16.6.3 RECENT DEVEOPMENT 274
16.7 B. BRAUN SE 275
16.7.1 COMPANY SNAPSHOT 275
16.7.2 PRODUCT PORTFOLIO 275
16.7.3 RECENT DEVEOPMENT 275
16.8 CREO MEDICAL GMBH 276
16.8.1 COMPANY SNAPSHOT 276
16.8.2 PRODUCT PORTFOLIO 276
16.8.3 RECENT DEVELOPMENT 276
16.9 DIVERSATEK, INC. 277
16.9.1 COMPANY SNAPSHOT 277
16.9.2 PRODUCT PORTFOLIO 277
16.9.3 RECENT DEVEOPMENT 277
16.10 DUOMED GROUP 278
16.10.1 COMPANY SNAPSHOT 278
16.10.2 PRODUCT PORTFOLIO 278
16.10.3 RECENT DEVEOPMENT 279
16.11 ENDOCLOT PLUS, INC. 280
16.11.1 COMPANY SNAPSHOT 280
16.11.2 PRODUCT PORTFOLIO 280
16.11.3 RECENT DEVEOPMENT 281
16.12 ERBE ELEKTROMEDIZIN GMBH 282
16.12.1 COMPANY SNAPSHOT 282
16.12.2 PRODUCT PORTFOLIO 282
16.12.3 RECENT DEVELOPMENT 283
16.13 FUJIFILM HOLDINGS CORPORATION 284
16.13.1 COMPANY SNAPSHOT 284
16.13.2 REVENUE ANALYSIS 284
16.13.3 PRODUCT PORTFOLIO 285
16.13.4 RECENT DEVELOPMENT 289
16.14 JOHNSON & JOHNSON (ETHICON) 290
16.14.1 COMPANY SNAPSHOT 290
16.14.2 REVENUE ANALYSIS 290
16.14.3 PRODUCT PORTFOLIO 291
16.14.4 RECENT DEVEOPMENT 292
16.15 KARL STORZ SE & CO. KG, TUTTLINGEN 293
16.15.1 COMPANY SNAPSHOT 293
16.15.2 PRODUCT PORTFOLIO 293
16.15.3 RECENT DEVEOPMENT 293
16.16 MEDITALIA S.R.L. 294
16.16.1 COMPANY SNAPSHOT 294
16.16.2 PRODUCT PORTFOLIO 294
16.16.3 RECENT DEVELOPMENT 295
16.17 MICRO-TECH ENDOSCOPY 296
16.17.1 COMPANY SNAPSHOT 296
16.17.2 PRODUCT PORTFOLIO 296
16.17.3 RECENT DEVELOPMENT 297
16.18 MTW ENDOSKOPIE MANUFAKTU 298
16.18.1 COMPANY SNAPSHOT 298
16.18.2 PRODUCT PORTFOLIO 298
16.18.3 RECENT DEVEOPMENT 298
16.19 OVESCO ENDOSCOPY AG 299
16.19.1 COMPANY SNAPSHOT 299
16.19.2 PRODUCT PORTFOLIO 299
16.19.3 RECENT DEVEOPMENT 300
16.20 PENTAX MEDICAL 301
16.20.1 COMPANY SNAPSHOT 301
16.20.2 SOLUTION PORTFOLIO 301
16.20.3 RECENT DEVELOPMENT 301
16.21 STERIS 302
16.21.1 COMPANY SNAPSHOT 302
16.21.2 REVENUE ANALYSIS 302
16.21.3 PRODUCT PORTFOLIO 303
16.21.4 RECENT DEVELOPMENT 306
17 COMPANY PROFILES DISTRIBUTOR 307
17.1 BOSTON IVY HEALTHCARE SOLUTIONS PRIVATE LIMITED 307
17.1.1 COMPANY SNAPSHOT 307
17.1.2 PRODUCT PORTFOLIO 307
17.1.3 RECENT DEVELOPMENT 307
17.2 CARDINAL HEALTH 308
17.2.1 COMPANY SNAPSHOT 308
17.2.2 REVENUE ANALYSIS 308
17.2.3 PRODUCT PORTFOLIO 309
17.2.4 RECENT DEVEOPMENT 309
17.3 HENRY SCHEIN, INC. 310
17.3.1 COMPANY SNAPSHOT 310
17.3.2 REVENUE ANALYSIS 310
17.3.3 PRODUCT PORTFOLIO 311
17.3.4 RECENT DEVEOPMENT 311
17.4 MCKESSON MEDICAL-SURGICAL INC. 312
17.4.1 COMPANY SNAPSHOT 312
17.4.2 PRODUCT PORTFOLIO 312
17.4.3 RECENT DEVEOPMENT 313
17.5 MFI MEDICAL 314
17.5.1 COMPANY SNAPSHOT 314
17.5.2 PRODUCT PORTFOLIO 314
17.5.3 RECENT DEVEOPMENT 314
18 QUESTIONNAIRE 315
19 RELATED REPORTS 318
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security